SCHEMBL4735958

SCHEMBL4735958

COBOc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA4 P22748 2/20 0.50
LTA4H P09960 5/20 0.42
TSHR P16473 1/20 0.41
NR1H2 P55055 1/20 0.37
BAX Q07812 1/20 0.37
KCNA3 P22001 1/20 0.35
TRPA1 O75762 1/20 0.33
CA5A P35218 1/20 0.33
CA5B Q9Y2D0 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
CA14 Q9ULX7 1/20 0.33
MAOB P27338 1/20 0.32
LMNA P02545 1/20 0.32
HTR1D P28221 1/20 0.32
HTR1B P28222 1/20 0.32
MAOA P21397 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8885 0.83 LTA4H (0.50) CA4LTA4HTSHRNR1H2BAX
Hydrochloric Acid SCHEMBL693111 0.80 LTA4H (0.47) CA4LTA4HTSHRNR1H2BAX
SCHEMBL4531186 0.79 CA4 (0.43) CA4LTA4HTSHRNR1H2BAX
SCHEMBL29544396 0.78 LTA4H (0.45) CA4LTA4HTSHRNR1H2BAX
SCHEMBL28591821 0.77 KMT2A (0.41) CA4TSHRHPGDSMN1; SMN2
SCHEMBL8100627 0.75 CA4 (0.41) CA4LTA4HTSHRKCNA3MAOB
SCHEMBL449851 0.74 LTA4H (0.63) LTA4HTSHRNR1H2BAXCA1
SCHEMBL4697871 0.74 LTA4H (0.41) CA4LTA4HTSHRNR1H2BAX
SCHEMBL1162702 0.74 LTA4H (0.41) CA4LTA4HTSHRNR1H2BAX
SCHEMBL365524 0.74 LTA4H (0.41) CA4LTA4HTSHRNR1H2BAX

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10544167-B2 Compounds as stimuli-responsive probes, methods and applications thereof JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH (IN) 2020-01-28 US claimed
US-20180251478-A1 COMPOUNDS AS STIMULI-RESPONSIVE PROBES, METHODS AND APPLICATIONS THEREOF JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH (IN) 2018-09-06 US claimed
EP-3341384-A1 COMPOUNDS AS STIMULI-RESPONSIVE PROBES, METHODS AND APPLICATIONS THEREOF Jawaharlal Nehru Centre For Advanced Scientific Research (IN) 2018-07-04 EP claimed
WO-2017033163-A1 COMPOUNDS AS STIMULI-RESPONSIVE PROBES, METHODS AND APPLICATIONS THEREOF JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH (IN) 2017-03-02 WO claimed
CN-119546585-A Preparation, application and application of indole compound 上海济煜医药科技有限公司 2025-02-28 CN disclosed
US-10544167-B2 Compounds as stimuli-responsive probes, methods and applications thereof JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH (IN) 2020-01-28 US disclosed
US-20180251478-A1 COMPOUNDS AS STIMULI-RESPONSIVE PROBES, METHODS AND APPLICATIONS THEREOF JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH (IN) 2018-09-06 US disclosed
EP-3341384-A1 COMPOUNDS AS STIMULI-RESPONSIVE PROBES, METHODS AND APPLICATIONS THEREOF Jawaharlal Nehru Centre For Advanced Scientific Research (IN) 2018-07-04 EP disclosed
WO-2017033163-A1 COMPOUNDS AS STIMULI-RESPONSIVE PROBES, METHODS AND APPLICATIONS THEREOF JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH (IN) 2017-03-02 WO disclosed
US-20140155305-A1 THICKENING OF FLUIDS SCHLUMBERGER TECHNOLOGY CORPORATION (US) 2014-06-05 US disclosed
WO-2008061016-A1 N-SUBSTITUTED PIPERIDINYL 4 -ARYLSULFONAMIDES AS MODULATORS OF THE SECRETED FRIZZLED RELATED PROTEIN- 1 WYETH (US) 2008-05-22 WO disclosed
WO-2007123941-A2 CHROMANE AND CHROMENE DERIVATIVES AND USES THEREOF WYETH (US) 2007-11-01 WO disclosed
EP-1244446-B1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2006-11-02 EP disclosed
US-6858630-B2 Naphthimidazole derivatives and their use as thrombopoietin mimetics SMITHKLINE BEECHAM CORPORATION (US) 2005-02-22 US disclosed
US-20030083361-A1 Naphtho(1,2-d)imidazole derivatives; treating thrombocytopenia SMITHKLINE BEECHAM CORPORATION 2003-05-01 US disclosed
EP-1244446-A4 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2003-01-08 EP disclosed
EP-1244446-A1 THROMBOPOIETIN MIMETICS SmithKline Beecham Corporation (US) 2002-10-02 EP disclosed
WO-2001039773-A1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORPORATION (US) 2001-06-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10544167-B2 Compounds as stimuli-responsive probes, methods and applications thereof ROS1, SQOR, NOX4 CA4 1989/4885LTA4H 2053/4885TSHR 2305/4885
US-20030083361-A1 Naphtho(1,2-d)imidazole derivatives; treating thrombocytopenia MPL, THPO, TPO CA4 4630/4885LTA4H 3640/4885TSHR 122/4885
US-20180251478-A1 COMPOUNDS AS STIMULI-RESPONSIVE PROBES, METHODS AND APPLICATIONS THEREOF ROS1, SQOR, NOX4 CA4 1989/4885LTA4H 2053/4885TSHR 2305/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.